scieee Science in your language
[en] (orig)

S. pseudintermedius and S. aureus lineages with transmission ability circulate as causative agents of infections in pets for years

Abstract

Background: Staphylococcus pseudintermedius (SP) and Staphylococcus aureus (SA) are common colonizers of companion animals, but they are also considered opportunistic pathogens, causing diseases of diverse severity. This study focused on the identification and characterization of 33 coagulase-positive staphylococci isolated from diseased pets (28 dogs and five cats) during 2009–2011 in a veterinary hospital in Spain in order to stablish the circulating lineages and their antimicrobial resistance profile. Results: Twenty-eight isolates were identified as SP and five as SA. Nine methicillin-resistant (MR) isolates (27%) carrying the mecA gene were detected (eight MRSP and one MRSA). The 55% of SP and SA isolates were multidrug-resistant (MDR). MRSP strains were typed as ST71-agrIII-SCCmecII/III-(PFGE) A (n=5), ST68-agrIV-SCCmecV-B1/B2 (n=2), and ST258-agrII-SCCmecIV-C (n=1). SP isolates showed resistance to the following antimicrobials [percentage of resistant isolates/resistance genes]: penicillin [82/blaZ], oxacillin [29/mecA] erythromycin/clindamycin [43/erm(B)], aminoglycosides [18–46/aacA-aphD, aphA3, aadE], tetracycline [71/tet(M), tet(K)], ciprofloxacin [29], chloramphenicol [29/catpC221], and trimethoprim-sulfamethoxazole [50/dfrG, dfrK]. The dfrK gene was revealed as part of the radC-integrated Tn559 in two SP isolates. Virulence genes detected among SP isolates were as follow [percentage of isolates]: siet [100], se-int [100], lukS/F-I [100], seccanine [7], and expB [7]. The single MRSA-mecA detected was typed as t011-ST398/CC398-agrI-SCCmecV and was MDR. The methicillin-susceptible SA isolates were typed as t045-ST5/CC5 (n=2), t10576-ST1660 (n=1), and t005-ST22/CC22 (n=1); the t005-ST22 feline isolate was PVL-positive and the two t045-ST45 isolates were ascribed to Immune Evasion Cluster (IEC) type F. Moreover, the t10576-ST1660 isolate, of potential equine origin, harbored the lukPQ and scneq genes. According to animal clinical history and data records, several strains seem to have been acquired from different sources of the hospital environment, while some SA strains appeared to have a human origin. Conclusions: The frequent detection of MR and MDR isolates among clinical SP and SA strains with noticeable virulence traits is of veterinary concern, implying limited treatment options available. This is the first description of MRSA-ST398 and MRSP-ST68 in pets in Spain, as well the first report of the dfrK-carrying Tn559 in SP. This evidences that current transmissible lineages with mobilizable resistomes have been circulating as causative agents of infections among pets for years. Ruiz-Ripa, L.; Simón, C.; Ceballos, S.; Ortega, C.; Zarazaga, M.; Torres, C.; Gómez-Sanz, E.

Read accessible full text

S. pseudintermedius and S. aureus lineages with transmission ability circulate as causative agents of infections in pets for years

Author: Ruiz-Ripa, L.; Torres, C.; Ceballos, S.; Zarazaga, M.; Ortega, C.; Simón, C.; Gómez-Sanz, E.
Year: 2021
DOI: 10.1186/s12917-020-02726-4
Source: https://zaguan.unizar.es/record/99697/files/texto_completo.pdf
RESEARCH ARTICLE Open Access
S. pseudin e medius and S. au eus lineages
wi h ansmission abili y ci cula e as
causa i e agen s o in ec ions in pe s o
yea s
Lau a Ruiz-Ripa
1†
, Ca men Simón
2
, Sa a Ceballos
1
, Ca melo O ega
2
, My iam Za azaga
1
, Ca men To es
1
and
Elena Gómez-Sanz
3,4,1*†
Abs ac
Backg ound: S aphylococcus pseudin e medius (SP) and S aphylococcus au eus (SA) a e common colonize s o
companion animals, bu hey a e also conside ed oppo unis ic pa hogens, causing diseases o di e se se e i y. This
s udy ocused on he iden i ica ion and cha ac e iza ion o 33 coagulase-posi i e s aphylococci isola ed om
diseased pe s (28 dogs and i e ca s) du ing 2009–2011 in a e e ina y hospi al in Spain in o de o s ablish he
ci cula ing lineages and hei an imic obial esis ance p o ile.
Resul s: Twen y-eigh isola es we e iden i ied as SP and i e as SA. Nine me hicillin- esis an (MR) isola es (27%)
ca ying he mecA gene we e de ec ed (eigh MRSP and one MRSA). The 55% o SP and SA isola es we e mul id ug-
esis an (MDR). MRSP s ains we e yped as ST71-ag III-SCCmecII/III-(PFGE) A (n=5), ST68-ag IV-SCCmecV-B1/B2
(n=2), and ST258-ag II-SCCmecIV-C (n=1). SP isola es showed esis ance o he ollowing an imic obials [pe cen age
o esis an isola es/ esis ance genes]: penicillin [82/blaZ], oxacillin [29/mecA] e y h omycin/clindamycin [43/e m(B)],
aminoglycosides [18–46/aacA-aphD, aphA3, aadE], e acycline [71/ e (M), e (K)], cip o loxacin [29], chlo amphenicol
[29/ca
pC221
], and ime hop im-sul ame hoxazole [50/d G,d K]. The d K gene was e ealed as pa o he adC-
in eg a ed Tn559 in wo SP isola es. Vi ulence genes de ec ed among SP isola es we e as ollow [pe cen age o
isola es]: sie [100], se-in [100], lukS/F-I [100], sec
canine
[7], and expB [7]. The single MRSA-mecA de ec ed was yped as
011-ST398/CC398-ag I-SCCmecV and was MDR. The me hicillin-suscep ible SA isola es we e yped as 045-ST5/CC5
(n=2), 10576-ST1660 (n=1), and 005-ST22/CC22 (n=1); he 005-ST22 eline isola e was PVL-posi i e and he wo
045-ST45 isola es we e asc ibed o Immune E asion Clus e (IEC) ype F. Mo eo e , he 10576-ST1660 isola e, o
po en ial equine o igin, ha bo ed he lukPQ and scneq genes. Acco ding o animal clinical his o y and da a eco ds,
se e al s ains seem o ha e been acqui ed om di e en sou ces o he hospi al en i onmen , while some SA
s ains appea ed o ha e a human o igin.
(Con inued on nex page)
© The Au ho (s). 2021 Open Access This a icle is licensed unde a C ea i e Commons A ibu ion 4.0 In e na ional License,
which pe mi s use, sha ing, adap a ion, dis ibu ion and ep oduc ion in any medium o o ma , as long as you gi e
app op ia e c edi o he o iginal au ho (s) and he sou ce, p o ide a link o he C ea i e Commons licence, and indica e i
changes we e made. The images o o he hi d pa y ma e ial in his a icle a e included in he a icle's C ea i e Commons
licence, unless indica ed o he wise in a c edi line o he ma e ial. I ma e ial is no included in he a icle's C ea i e Commons
licence and you in ended use is no pe mi ed by s a u o y egula ion o exceeds he pe mi ed use, you will need o ob ain
pe mission di ec ly om he copy igh holde . To iew a copy o his licence, isi h p://c ea i ecommons.o g/licenses/by/4.0/.
The C ea i e Commons Public Domain Dedica ion wai e (h p://c ea i ecommons.o g/publicdomain/ze o/1.0/) applies o he
da a made a ailable in his a icle, unless o he wise s a ed in a c edi line o he da a.
* Co espondence: [email p o ec ed]
†
Lau a Ruiz-Ripa and Elena Gómez-Sanz con ibu ed equally o his wo k.
3
Ins i u e o Food, Nu i ion and Heal h, ETH Zü ich, Schmelzbe gs asse 7,
LFV B36, 8092 Zu ich, Swi ze land
4
Á ea de Mic obiología Molecula , Cen o de In es igación Biomédica de La
Rioja (CIBIR), Log oño 26006, Spain
Full lis o au ho in o ma ion is a ailable a he end o he a icle
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42
h ps://doi.o g/10.1186/s12917-020-02726-4
(Con inued om p e ious page)
Conclusions: The equen de ec ion o MR and MDR isola es among clinical SP and SA s ains wi h no iceable i ulence
ai s is o e e ina y conce n, implying limi ed ea men op ions a ailable. This is he i s desc ip ion o MRSA-ST398 and
MRSP-ST68 in pe s in Spain, as well he i s epo o he d K-ca ying Tn559 in SP. This e idences ha cu en ansmissible
lineages wi h mobilizable esis omes ha e been ci cula ing as causa i e agen s o in ec ions among pe s o yea s.
Keywo ds: MRSP, MRSA, MRSP-ST71, MRSA-CC398, Pe s, In ec ion, Tn559
Backg ound
S aphylococcus pseudin e medius (SP) and S aphylococ-
cus au eus (SA) a e ha mless colonize s o he skin and
mucosa o humans and animals [1], bu hey a e also e-
quen ly implica ed in oppo unis ic in ec ions. In pe s,
especially in dogs, SP is mos equen ly de ec ed han
SA, bo h as colonize and as causa i e agen o in ec ion.
I is ecognized as he mos common e iological agen
implica ed in skin and so issue in ec ions, o i is, and
u ina y ac in ec ions in dogs [2–4]. Mo eo e , SP can
also cause diseases in humans, specially associa ed wi h
dog exposu e, which sugges s zoono ic ansmission [4].
SA is also ound in heal hy pe s in a es be ween 8 and
12% [5–7].
Simila o me hicillin- esis an SA (MRSA) in he clin-
ical se ing, me hicillin- esis an SP (MRSP) has become
a wo ldwide p oblem in animal heal h. I is equen ly
associa ed wi h a mul id ug esis ance pheno ype, which
limi s he he apeu ic op ions o e e ina ians. Mo e-
o e , in ecen yea s, se e al epo s ha e e idenced an
inc ease in he esis ance a es o some impo an an i-
mic obials, such as luo oquinolones, in SP isola es e-
co e ed om companion animals in Eu opean coun ies
[8,9]. In SP isola es eco e ed om diseased dogs, p e i-
ous s udies ha e epo ed me hicillin esis ance a es
om 10 o 20% [8,10,11], al hough i a ies no ably de-
pending on he geog aphic egion. Howe e , he me hi-
cillin esis ance a e inc eases up o 60% in isola es
eco e ed om canine pyode ma [12]. The sp ead o
MRSP be ween coun ies is due o he dissemina ion o
well-known speci ic gene ic lineages such as he clone
ST71 in Eu ope, ST68 in he USA, and ST45/ST112 in
Asia [2–4,10,13], al hough all hese clones ha e sp ead
wo ldwide [4].
Rega ding SA, molecula cha ac e iza ion has e ealed ha
companion animals a e colonized o in ec ed by hospi al-
associa ed (HA) and communi y-associa ed (CA) MRSA
clones om humans in close con ac , which sugges s an
an h opozoono ic o igin [14,15]. Li es ock-associa ed (LA)
MRSA-CC398, which is mainly ela ed wi h li es ock and
people wi h li es ock con ac , has also been epo ed causing
in ec ions in pe s in ew occasions [15,16].
In his s udy, we iden i ied and pe o med he molecu-
la cha ac e iza ion o a collec ion o coagulase-posi i e
s aphylococci (CoPS) ob ained om diseased pe s du ing
a 3-yea -sampling pe iod (2009–2011) in he e e ina y
labo a o y a he Uni e si y o Za agoza, Spain.
Resul s
Isola es eco e ed and species iden i ica ion
O he 33 CoPS included in his s udy, 28 we e iden i ied
as SP and i e as SA. The in ec ion si e o he animals
om which samples we e eco e ed is indica ed in
Table 1and Supplemen a y Table 1. Nine me hicillin-
esis an isola es ca ying he mecA gene we e de ec ed
(eigh MRSP and one MRSA), ep esen ing 27% o he
s udied isola es; all o hem, excep one MRSP isola e,
we e eco e ed om dogs. The 55% o SP and SA iso-
la es we e mul id ug- esis an (MDR) ( esis an o a
leas h ee amilies o an imic obial agen s) (Table 1).
Rema kably, pe sis en MRSP o MRSA ca iage, based
on he molecula cha ac e is ics o eco e ed isola es,
was de ec ed in h ee animals e alua ed in subsequen
samplings. S ains in ol ed we e MRSP ST68 clone
C3870 (2 mon hs la e ), MRSP ST71 clone C3871 (1 yea
la e ) and MRSA ST398 clone C3883 (a e 3 mon hs).
None heless, only he ini ial isola e pe animal was in-
cluded in his s udy.
Cha ac e iza ion o SP isola es
Fi e o he eigh MRSP, eco e ed om di e se in ec ion
ypes, we e yped as ST71, ag -III, ha bo ed he S aphylo-
coccal Casse e Ch omosome mec (SCCmec) II-III, and
belonged o he same clone (A). Two MRSP eco e ed
om u ina y- ep oduc i e in ec ions we e yped as ST68,
ag -IV, SCCmec V, and ep esen ed wo di e en sub-
clones (B1 and B2). The emaining MRSP isola e, also
om a u ina y in ec ion, was yped as ST258, ag -II,
SCCmec IV, and displayed pulsed- ield gel elec opho esis
(PFGE) pa e n C.
The an imic obial esis ance a es o he me hicillin-
suscep ible SP (MSSP) and MRSP isola es, a e shown in
Fig. 1. Resis ance o e y h omycin, clindamycin, kanamy-
cin, s ep omycin, cip o loxacin, and ime hop im-
sul ame hoxazole we e signi ican ly highe among MRSP
isola es. Mo eo e , esis ance o gen amicin and ob a-
mycin we e solely de ec ed in MRSP isola es (Fig. 1).
Eigh ou o 28 SP isola es we e MRSP (29%). Nine
MSSP and all MRSP isola es we e MDR, while wo
MSSP we e suscep ible o all an imic obial agen s
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 2 o 10
Table 1 Cha ac e iza ion o he 28 S. pseudin e medius and i e S. au eus isola es eco e ed om clinical samples o dogs and ca s in
his s udy
S ain Bac e ial
species
Yea Animal Type o
in ec ion
a
spa-MLST/CC-
ag -SCCmec
An imic obial esis ance
pheno ype
b
An imic obial esis ance
geno ype
Vi ulence
genes
de ec ed
C3871
c
MRSP 2009 Dog B-J ST71-ag III-
SCCmecII-III
PEN-OXA-ERY-CLI-GEN-TOB-
KAN-STR-TET-CIP
-CHL-SXT
blaZ,mecA,e m(B), aacA/aphD,
aphA3,aadE, e (K), ca
pC221
,d G
lukS/F-I, sie , se-
in
C3880 MRSP 2010 Dog S ST71-ag III-
SCCmecII-III
PEN-OXA-ERY-CLI-GEN-TOB-
STR-TET-CIP
-CHL-SXT
blaZ,e m(B), aacA/aphD,aphA3,
aadE, e (K), ca
pC221
, d G
lukS/F-I, sie , se-
in
C3885 MRSP 2010 Dog I ST71-ag III-
SCCmecII-III
PEN-OXA-ERY-CLI-GEN-TOB-
KAN-STR-TET-CIP
-CHL-SXT
blaZ,e m(B), aacA/aphD,aphA3,
aadE, e (K), ca
pC221
,d G
lukS/F-I, sie , se-
in
C5355 MRSP 2010 Dog B-J ST71-ag III-
SCCmecII-III
PEN-OXA-ERY-CLI-GEN-TOB-
KAN-STR-CIP
-SXT
blaZ,mecA,e m(B), aacA/aphD,
aphA3,aadE,d G
lukS/F-I, sie , se-
in
C5613 MRSP 2011 Dog U-R ST71-ag III-
SCCmecII-III
PEN-OXA-ERY-CLI-GEN-TOB-
KAN-STR-TET-CIP
-CHL-SXT
blaZ,mecA,e m(B), aacA/aphD,
aphA3,aadE, e (K), ca
pC221
,d G
lukS/F-I, sie , se-
in
C3866 MRSP 2009 Ca U-R ST68-ag IV-
SCCmecV
PEN-OXA-ERY-CLI-KAN-STR-
TET-CIP
-SXT
blaZ,mecA, e (M), e m(B), aphA3,
aadE,d G
lukS/F-I, sie , se-
in
C3870
d
MRSP 2009 Dog U-R ST68-ag IV-
SCCmecV
PEN-OXA-ERY-CLI-KAN-STR-
TET-CIP
-SXT
blaZ,mecA,e m(B), aphA3,aadE,
e (M), d G
lukS/F-I, sie , se-
in
C3869 MRSP 2009 Dog U-R ST258-ag II-
SCCmecIV
PEN-OXA-ERY-CLI-KAN-STR-
TET-SXT
blaZ,mecA,e m(B), aphA3,aadE,
e (M), d G
lukS/F-I, sie , se-
in
C5344 MSSP 2009 Dog U-R PEN-ERY-CLI-KAN-STR-TET-
CHL-SXT
blaZ,e m(B), aphA3,aadE, e (M),
ca
pC221
,d G
lukS/F-I, sie , se-
in
C5345 MSSP 2009 Ca SI PEN-ERY-CLI-KAN-STR-TET-
CHL-SXT
blaZ,e m(B), aphA3,aadE, e (M),
ca
pC221
,d G
lukS/F-I, sie , se-
in
C5360 MSSP 2011 Dog U-R PEN-ERY-CLI-KAN-STR-TET-
CHL-SXT
blaZ,e m(B), aphA3,aadE, e (M),
e (K), d G,ca
pC221
lukS/F-I, sie , se-
in
C5347 MSSP 2009 Dog U-R PEN-ERY-CLI-TET-CHL-SXT blaZ,e m(B), e (M), ca
pC221
,d G,
d K
h
lukS/F-I, sie , se-
in
C3877 MSSP 2010 Dog U-R PEN-KAN-STR-TET blaZ,aphA3,aadE, e (M) lukS/F-I, sie , se-
in , expB
C5351 MSSP 2010 Ca U-R PEN-KAN-TET blaZ,aphA3, e (M) lukS/F-I, sie , se-
in
C3881 MSSP 2010 Dog U-R STR-TET-CIP
s , e (K), e (M) lukS/F-I, sie , se-
in
C5354 MSSP 2010 Dog U-R PEN-TET-SXT blaZ, e (M), d G lukS/F-I, sie , se-
in
C5358 MSSP 2011 Dog U-R PEN-TET-SXT blaZ, e (M), d G,d K
h
lukS/F-I, sie , se-
in
C3875 MSSP 2010 Dog I PEN-TET blaZ, e (M) lukS/F-I, sie , se-
in
C3876 MSSP 2010 Dog U-R PEN-TET blaZ, e (M) lukS/F-I, sie , se-
in , expB
C5356 MSSP 2011 Dog U-R PEN-TET blaZ, e (M) lukS/F-I, sie , se-
in
C5362 MSSP 2011 Dog I PEN-TET blaZ, e (M) lukS/F-I, sie , se-
in
C5353 MSSP 2010 Dog U-R TET e (M) lukS/F-I, sie , se-
in , sec
canine
C3873 MSSP 2010 Dog U-R PEN blaZ lukS/F-I, sie , se-
in
C3878 MSSP 2010 Dog U-R PEN blaZ lukS/F-I, sie , se-
in
C3879 MSSP 2010 Dog I PEN blaZ lukS/F-I, sie , se-
in , sec
canine
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 3 o 10
Table 1 Cha ac e iza ion o he 28 S. pseudin e medius and i e S. au eus isola es eco e ed om clinical samples o dogs and ca s in
his s udy (Con inued)
S ain Bac e ial
species
Yea Animal Type o
in ec ion
a
spa-MLST/CC-
ag -SCCmec
An imic obial esis ance
pheno ype
b
An imic obial esis ance
geno ype
Vi ulence
genes
de ec ed
C5357 MSSP 2011 Dog U-R PEN blaZ lukS/F-I, sie , se-
in
C3874 MSSP 2010 Dog I Suscep ible –lukS/F-I, sie , se-
in
C5359 MSSP 2011 Dog U-R Suscep ible –lukS/F-I, sie , se-
in
C3883
e
MRSA 2010 Dog S 011-ST398/
CC398-ag I-
SCCmecV
PEN-FOX-ERY-CLI-GEN-TOB-
KAN-TET-CIP
g
-SXT
blaZ,mecA,e m(B), e m(C), aacA/
aphD, e (M), e (K), d A,d G
hla,hlb,hld,hlg
C5612 MSSA 2009 Dog U-R 10576-ST1660-
ag II
PEN blaZ lukPQ,scneq,
hla,hlb,hld,
hlg
C5650 MSSA 2009 Ca R 005-ST22/CC22-
ag I
PEN blaZ lukS/F-PV, hla,
hlb,hld,hlg
C5610 MSSA 2011 Dog U-R 045-ST5/CC5-
ag II
PEN blaZ IEC ype F,
lukED,hla,hld,
hlg
C5609 MSSA 2011 Ca I 045-ST5/CC5-
ag II
Suscep ible –IEC ype F,
lukED,hla,hld,
hlg
a
B-J, bones-join s in ec ion; U-R, u ina y- ep oduc i e in ec ion; R, espi a o y in ec ion; I, in egumen a y in ec ion; S, su gical in ec ion; SI, sep ic in ec ion
b
PEN, penicillin; OXA, oxacillin; FOX, ce oxi in; ERY, e y h omycin; CLI, clindamycin; GEN, gen amicin; TOB, ob amycin; KAN, kanamycin; STR, s ep omycin; TET,
e acycline; CIP, cip o loxacin; CHL, chlo amphenicol; SXT, ime hop im-sul ame hoxazole
c
Isola ed again one yea la e o he i s eco e y
d
Isola ed again wo mon hs la e o he i s eco e y
e
Isola ed again h ee mon hs la e o he i s eco e y
Amino acid change S84L and S80I in Gy A and G lA p o eins, espec i ely
g
Amino acid change S84L and S80F in Gy A and G lA p o eins, espec i ely
h
The d K gene was loca ed wi hin he adC-in eg a ed Tn559
Fig. 1 An imic obial esis ance a e o MSSP and MRSP in es iga ed in his s udy. PEN, penicillin; ERY, e y h omycin; CLI, clindamycin; GEN,
gen amicin; TOB, ob amycin; KAN, kanamycin; STR, s ep omycin; TET, e acycline; CIP, cip o loxacin; CHL, chlo amphenicol; SXT, ime hop im-
sul ame hoxazole. The p- alue (Fishe ’s Exac es ) is shown below he igu e. As e isks indica e he an imic obial agen s o which s a is ical
di e ences we e ound be ween he an imic obial esis ance a es o MSSP and MRSP (P < 0.05)
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 4 o 10
e alua ed. The blaZ and/o mecA esis ance genes we e
esponsible o β-lac am esis ance in SP isola es. Mac o-
lide and lincosamide esis ance was media ed by he
e m(B) gene in all cases, and aminoglycoside esis ance
by di e en combina ions o aacA/aphD,aphA3, and
aadE esis ance genes. The e (M) and/o e (K) genes
media ed e acycline esis ance. The eigh isola es exhi-
bi ing chlo amphenicol esis ance ha bo ed he ca
pC221
gene, while he d G gene was de ec ed in he 14 isola es
ha displayed esis ance o ime hop im–sul ame hoxa-
zole, in combina ion wi h d K in wo s ains (C5358,
C5347) (Table 1). The amino acid changes S84L and
S80I in he genes encoding he Gy A and G lA p o eins,
espec i ely, we e de ec ed in he eigh cip o loxacin-
esis an SP isola es. None o he SP isola es showed e-
sis ance o ancomycin, linezolid, o usidic acid.
The i ulence genes de ec ed among SP isola es we e
as ollows: sie (100%), se-in (100%), lukS/F-I (100%),
sec
canine
(7%), and expB (7%).
Cha ac e iza ion o SA isola es
The single MRSA isola e de ec ed was yped as 011-
ST398/CC398-ag I-SCCmecV and was eco e ed om a
su gical in ec ion o a dog. This ST398 s ain was esis -
an o β-lac ams, mac olides and lincosamides, amino-
glycosides, e acycline, cip o loxacin, and ime hop im-
sul ame hoxazole, and ca ied he blaZ,mecA,e m(B),
e m(C), aacA/aphD, e (K), e (M), d A, and d G esis -
ance genes. Mo eo e , he amino acid changes S84L and
S80F in he deduced sequences o Gy A and G lA p o-
eins, espec i ely, we e de ec ed. The MRSA isola e ha -
bo ed he haemolysins hla,hlb,hld,andhlg (Table 1).
The me hicillin-suscep ible SA (MSSA) isola es we e
assigned o 045-ST5/CC5 (n=2), 10576-ST1660 (n=1),
and 005-ST22/CC22 (n=1). One MSSA isola e was sus-
cep ible o all an imic obial agen s e alua ed, and he
emaining h ee only showed penicillin esis ance and
ca ied he blaZ gene. The MSSA 005-ST22 eline iso-
la e ha bo ed he genes enconding he Pan on-Valen ine
leukocidin (PVL) and he wo MSSA 045-ST45 ca ied
he scn,chp,sak, and sep genes and, he e o e, we e as-
c ibed o Immune E asion Clus e (IEC) ype F. In e es -
ingly, he 10576-ST1660 isola e ca ied he equid-
adap ed leukocidin lukPQ and he equine a ian o
S aphylococcal Complemen Inhibi o (SCIN). Di e en
combina ions o haemolysins, encoded by hla,hlb,hld,
hlg, and hlg
, we e de ec ed among MSSA isola es
(Table 1).
Gene ic en i onmen o he d K gene
The Tn559-speci ic PCRs e ealed ha he MSSP C5358
ha bo ed a comple e Tn559, which was in eg a ed in he
ch omosomal adC gene. De ec ion o he adC gene
and he Tn559- adC linkage was no possible o s ain
MSSP C5347. The whole genome sequencing (WGS)
analysis o his s ain enabled he iden i ica ion o he
comple e Tn559 and i s in eg a ion posi ion (Fig. 2)
(GenBank accession numbe MT252966). Nucleo ide
and amino acid sequence alignmen o Tn559 C5347
wi h e e ence S aphylococcus au eus ansposon Tn559
(GenBank accession numbe FN677369) e ealed he in-
se ion o one nucleo ide and h ee nucleo ide subs i u-
ions in he non-coding egion downs eam he d K
gene (Fig. 2). Rema kably, a single poin mu a ion in he
hyb idiza ion sequence o he adC o wa d p ime was
de ec ed ( adC- w: 5′-GTC/AGGAATAGGGCGTA-3′),
which esul ed esponsible o he absence o PCR amp-
li ica ion. Mo eo e , nucleo ide and amino acid align-
men wi h he adC gene o S. pseudin e medius s ain
C2719, ha bo ing ansposon Tn558 (GenBank accession
numbe HF679552), e ealed he p esence o se en syn-
onymous poin mu a ions (C27T, G114C, C219A,
C301T, G444C, T516C, G540T) plus wo addi ional
non-synonymous subs i u ions in he deduced RadC se-
quence (K63N, A103D) (Fig. 2). Tn559 ci cula in e me-
dia es we e de ec ed.
Discussion
This is he i s desc ip ion o MRSA-ST398 and MRSP-
ST68 in pe s in Spain, as well he i s epo o he
d K-ca ying Tn559 in SP. This e idences ha cu en
ansmissible lineages wi h mobilizable esis omes ha e
ci cula ed unno iceably in Spain as causa i e agen s o
in ec ions in pe s o yea s.
In his s udy, 28 o he 33 CoPS om diseased pe s
we e iden i ied as SP, which was expec ed since his is
he mos common s aphylococcal species de ec ed bo h
as colonize and cause o in ec ion in companion ani-
mals, specially dogs [4,5]. In his wo k, SP and SA we e
de ec ed causing in ec ion in h ee and wo ca s, espec -
i ely. These species ha e been o me ly eco e ed om
diseased ca s [1,17], howe e , a ecen s udy has e-
po ed p edominance o o he s aphylococcal species,
such as S. elis and S. haemoly icus, among eline in ec-
ions [1].
Fi e o he eigh MRSP isola es de ec ed in his s udy
we e asc ibed o he gene ic lineage ST71 and showed
he same PFGE pa e n. They we e isola ed om i e di -
e en dogs in di e en yea s and he e was no appa en
ela ion among hese animals; howe e , all o hem
unde wen su ge y in he e e ina y hospi al. Rega dless
hey we e assis ed by di e en e e ina ians, and he op-
e a ing oom and/o su ge y ma e ial a e ecu en ly dis-
in ec ed, none o hem can be excluded as po en ial
in ec ion sou ces. MRSP-ST71 is he majo clone in Eu -
ope [2,3], and he e a e al eady ew desc ip ions o his
gene ic lineage in heal hy dogs in Spain [18]. Howe e ,
ecen s udies ha e epo ed a downwa d end in he
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 5 o 10

Fig. 2 aG aphical ep esen a ion o he Tn559 s uc u e con aining he d K gene in eg a ed in he ch omosomal adC gene o he isola e S aphylococcus
pseudin e medius C5347 (GenBank accession numbe MT252966) and nucleo ide subs i u ions de ec ed in he non-coding egion downs eam he d K gene
compa ed o S aphylococcus au eus ansposon Tn559 (GenBank accession numbe FN677369). The nucleo ide posi ions a e se based on he whole Tn559.
Nucleo ide inse ions and subs i u ions a e colo ed in yellow. bAmino acid sequence alignmen o adC gene and esul an RadC o S aphylococcus
pseudin e medius s ain C2719 (GenBank accession numbe HF679552), whe e ansposon Tn558 was in eg a ed, ha o S. pseudin e medius C5347 (GenBank
accession numbe MT252966). The posi ion o he p ime pai employed is indica ed in g ey. Nucleo ide subs i u ions a e colo ed in yellow and amino acid
subs i u ions in blue
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 6 o 10
p e alence o he MRSP-ST71 lineage among compan-
ion animals in no he n Eu ope [11,19] and F ance [3].
The MRSP-ST258 lineage, which was de ec ed in his
s udy in 2009, seems o be eplacing MRSP-ST71 in
hese coun ies [11,19]. The emaining wo MRSP de-
ec ed in his s udy belonged o he ST68, a gene ic
lineage known o be p edominan in USA, al hough i
has been de ec ed ou side his coun y [4]. Howe e , o
he bes o ou knowledge, his is he i s desc ip ion o
MRSP-ST68 isola ed om companion animals in Spain.
Fo me s udies epo ed MRSA belonging o he HA-
MRSA and CA-MRSA lineages among isola es eco e ed
om companion animals [9,15]; howe e , in his wo k,
he only MRSA isola e de ec ed belonged o he LA-
MRSA CC398 gene ic lineage. Mo eo e , his isola e
lacked he genes o he IEC sys em, which sugges s an
animal o igin. LA-MRSA CC398 eco e ed om dis-
eased dogs has been epo ed in ew occasions [9,15,
16], howe e , o ou knowledge, his is he i s desc ip-
ion in Spain. Rega ding MSSA, isola es belonging o
CC22 and CC5 a e clonal g oups widesp ead among
companion animals [9,15,20]. The emaining MSSA
isola e was yped as 10576-ST1660, and, in e es ingly,
he single desc ip ion o his gene ic lineage is in a con-
empo a y isola e (ob ained in he same week) eco e ed
om one hospi alized equine in he same e e ina y hos-
pi al, which displayed he same an imic obial esis ance
pheno/geno ype and i ulence gene con en [21]. Mo e-
o e , he SA 10576-ST1660 isola e eco e ed in his
s udy ha bo ed he leukocidin lukPQ and he scneq,
which a e equid-adap ed i ulence ac o s [22,23]. This
suppo s he hypo hesis o a plausible equine o igin and
sugges s he ansmission o he MSSA s ain be ween
animal species in he e e ina y hospi al.
The equency o me hicillin esis ance and MDR iso-
la es among CoPS eco e ed om pe s in his s udy ep-
esen s a g ea conce n o e e ina y medicine. This is
also a public heal h p oblem due o he exposu e and in-
e species ansmission o SA/SP among pe s and
owne s [6,24], as well as po en ial ans e ence o esis -
ance genes o human-adap ed s aphylococcal s ains.
The a e o me hicillin esis ance obse ed in his s udy
(27%) is highe han he one de e mined among clinical
isola es om companion animals in se e al coun ies,
such as Aus alia (12%) [10,17], Finland (14%) [19], he
Ne he lands [11], and F ance [8]. As in his epo ,
MRSP-ST71 a e o en MDR [2,11], and hey a e mo e
likely o display luo oquinolone esis ance han o he
STs [10,11]. Fo una ely, in line wi h o me epo s, all
isola es eco e ed he e, bo h SA and SP, we e suscep-
ible o impo an o las eso an imic obials in human
medicine, such as ancomycin and linezolid [2,9].
All SP isola es, bo h MSSP and MRSP, ca ied he
i ulence de e minan s lukS/F-I, sie , and se-in , which
ha e been p e iously de ec ed in bo h commensal and
clinical SP isola es, sugges ing hey may be ubiqui ous in
his s aphylococcal species [5,18,20]. One MSSA 005-
ST22/CC2 eco e ed om a espi a o y in ec ion o a
ca was PVL-posi i e. The PVL is one o he mos im-
po an i ulence de e minan s p oduced by SA, which
has a c i ical ole in he pa hogenesis o skin and so is-
sue in ec ions. CC22 is an impo an gene ic lineage o
PVL-posi i e MSSA also implica ed in hospi al ou -
b eaks [25,26]. Mo eo e , he wo MSSA 045-ST5/CC5
isola es ca ied he human-adap ed scn,chp,sak, and sep
genes o he IEC sys em, which sugges s a human- o-
animal ansmission. To his ega d, o me s udies ha e
de e mined he in e species ansmission abili y o SA
om humans o pe s [6,24], which ep esen s a sou ce
o u he ansmission and a isk o in ec ion.
The d K gene has been a ely de ec ed in SP isola es
[9,27]. Indeed, he d K-ca ying ansposon Tn559 was
i s ly epo ed in a po cine MSSA ST398 isola e [28]
and he ea e in SA belonging o he same gene ic
lineage [21], bu also in En e ococcus aecium [29]. How-
e e , o he bes o ou knowledge, we epo he e he
i s desc ip ion o he Tn559 in SP. This could sugges
an exchange o esis ance genes be ween s aphylococci
and o he G am-posi i e bac e ia, including en e ococci,
o animal bu also om human o igin.
Conclusions
P esen ly ele an MRSP and MRSA gene ic lineages
wi h no iceable i ulence ai s we e de ec ed in isola es
eco e ed du ing 2009–2011, including he i s desc ip-
ion o MRSA ST398 and MRSP ST68 in pe s in Spain.
In addi ion, he appa en dissemina ion o CoPS s ains
in he e e ina y hospi al highligh s he impo ance o
u he in es iga ing SA and SP sou ces and su i al
abili y as con aminan s, hei popula ion s uc u e and
epidemiology, as well as hei an imic obial esis ance
pa e n and ansmission abili y.
Me hods
S udy popula ion
A o al o 33 CoPS isola es ob ained om 28 and i e
diseased dogs and ca s (one isola e/animal), espec i ely,
we e ob ained in he Ve e ina y Labo a o y o he Uni-
e si y o Za agoza (Za agoza, Spain) du ing he yea s
2009 (9 isola es), 2010 (15), and 2011 (9), and we e in-
cluded in his s udy. The samples we e aken om he
in ec ion si e (Supplemen a y Table S1). The isola es
we e s o ed ozen a −80 °C un il hey we e s udied.
Isola ion and iden i ica ion o SP and SA isola es
Iden i ica ion o isola es was pe o med by biochemical as-
says, including colony mo phology, G am s aining, ca a-
lase and DNase ac i i ies, and API20-STAPH. The
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 7 o 10
iden i ica ion o SA and SP was de e mined by a mul iplex
PCR ha ampli ies he speci ic nuc gene o SA o S. in e -
medius/SP [30]. Disc imina ion be ween S. in e medius
and SP was ca ied ou by diges ion o he p a gene ampli-
con wi h MboIenzyme[31].
Molecula yping and clonal ela edness
All SA we e subjec ed o spa- yping by PCR and ampli-
con sequencing, and he ob ained sequences we e ana-
lyzed using Ridom S aph-Type so wa e e sion 1.5.21
(Ridom GmbH, Müns e , Ge many) [32]. Mul i Locus
Sequence Typing (MLST) was pe o med in all SA iso-
la es [32], and acco ding o he sequence- ype (ST), he
isola es we e asc ibed o he di e en clonal complexes
(CC). MLST o SP isola es was likewise pe o med as
p e iously desc ibed [33]. All isola es we e cha ac e ized
by ag - yping ollowing s anda d me hodology [32,33].
SCCmec- yping was unde gone in MRSP and MRSA as
p e iously desc ibed [13,34].
PFGE o o al DNA es ic ed wi h SmaIenzymewaspe -
o med on MRSP as p e iously desc ibed [35]. Isola es we e
conside ed di e en clones when hey exhibi ed mo e han
h ee bands o di e ence in PFGE band pa e ns and sub-
clones when PFGE band pa e ns di e ed be ween 1 and 3
bands [36].
An imic obial esis ance pheno ype and geno ype
The suscep ibili y o 17 an imic obials was de e mined
by aga disk-di usion me hod. The an imic obial agen s
es ed we e as ollows (μg/disk): penicillin (10 uni s),
oxacillin (1), ce oxi in (30) e y h omycin (15), clindamy-
cin (2), gen amicin (10), ob amycin (10), kanamycin
(30), s ep omycin (10), e acycline (30), cip o loxacin
(5), mupi ocin (200), ancomycin (30), chlo amphenicol
(30), linezolid (30), usidic acid (10), and ime hop im-
sul ame hoxazole (1.25+ 23.75). The CLSI guidelines
[37] was used o all an imic obials, excep o s ep o-
mycin, mupi ocin, and usidic acid, o which he
me hods and b eakpoin s ecommended by he Socié é
F ançaise de Mic obiologie [38] we e employed.
The p esence o 34 an imic obial esis ance genes was in-
es iga ed by PCR: mecA,blaZ,e m(A), e m(B), e m(C),
e m(T), mph(C), ms (A), ms (B), lnu(A), ga(A), ga(C),
aacA-aphD, aphA3, aadE,aadD,aadA, s , e (K), e (M),
e (L), sa 4 (e en hough s ep o h icin suscep ibili y was no
es ed), exA, exB, c , op A, pox A, ca
ps194
,ca
pC221
,
ca
pC223
,d A,d D,d G,andd K[18,39,40]. Posi i e con-
ols om he collec ion o he Uni e si y o La Rioja we e
included in all PCR assays.
Mu a ions in he genes encoding he Gy A and G lA p o-
eins we e in es iga ed in cip o loxacin- esis an SA and SP
isola es by PCR and sequencing [18,41]. The co esponding
sequences o S. au eus NCTC 8325 (GenBank accession
numbe CP000253) and S. pseudin e medius KM1381
(GenBank accession numbe AM262969 and AM262972)
we e used as e e ences.
De ec ion o i ulence genes
The p esence o he leukocidin genes lukSF-PV, lukM,
lukED,andlukPQ was in es iga ed in all SA isola es [21,
23]. They we e also sc eened o he p esence o haemoly-
sin genes (hla,hlb,hld,hlg,andhlg
), ex olia i e genes
(e a,e b,ande d), and he oxic shock synd ome oxin-1
( s )[21]. PCR-based de e mina ion o he i e genes (scn,
chp,sak,sea, and sep) ha comp ises he IEC sys em as
well he equine a ian o SCIN encoded by scneq we e
likewise in es iga ed [32,42]. In addi ion, SP isola es we e
sc eened o he p esence o he leukocidin gene lukS/F-I,
he ex olia i e genes sie ,expA,andexpB, and he en e o-
oxin genes si-en and sec
canine
by PCR [20].
S a is ical analysis
Po en ial s a is ical di e ences be ween he an imic obial
esis ance a es in MRSP and MSSP isola es we e com-
pa ed using he Fishe ’s Exac es wi h he R Com-
mande p og am. P< 0.05 was conside ed a s a is ically
signi ican esul .
Gene ic en i onmen o he d K gene in S.
pseudin e medius isola es
The possibili y ha he d K gene was loca ed wi hin he
Tn559 and in eg a ed wi hin he ch omosomal adC
gene was in es iga ed by speci ic PCRs a ge ing he di -
e en cons i uen s o Tn559 and hei physical linkage
o adC, as p e iously desc ibed [21,43]. S ains nega-
i e o a leas one p ime combina ion we e submi ed
o WGS.
Whole genome sequencing o Tn559 ca ying s ain
nega i e o adC in eg a ion
WGS was pe o med on SP s ain C5347 using PacBio Se-
quel and Illumina Miseq 2 × 300 bp pla o ms p io phenol-
chlo o o m DNA ex ac ion, as p e iously desc ibed [44].
Raw PacBio eads we e assembled using Canu [45]wi hde-
aul pa ame e s and se ing an es ima ed genome size o 3
Mb. The esul ing assembled con igs we e hen polished as
ollows: Fi s , Illumina aw eads we e quali y- immed using
T immoma ic [46] and aligned agains he assembled PacBio
con igs using Bow ie2 [47]. Then, he esul ing bam iles
we e used o ix indi idual base e o s, indels and local mis-
sassemblies using Pilon [48].
Resul ing genes on he assembled con igs we e p edic ed
using P odigal [49]. RNA and RNA genes we e p edic ed
using RNAscan-SE [50], ssu-align [51] and me a- na [52].
P edic ed p o ein sequences we e compa ed agains he
NCBI n da abase using DIAMOND [53], and agains COG
[54]andTIGFRAM[55] using HMMscan [56] o axo-
nomic and unc ional anno a ion.
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 8 o 10
Supplemen a y In o ma ion
The online e sion con ains supplemen a y ma e ial a ailable a h ps://doi.
o g/10.1186/s12917-020-02726-4.
Addi ional ile 1: Table S1. Type o in ec ion, sample and sampling
me hod used o ob ain he hi y- h ee coagulase-posi i e s aphylococci
o his s udy.
Abb e ia ions
SP: S aphylococcus pseudin e medius; SA: S aphylococcus au eus;
MR: me hicillin- esis an ; MDR: mul id ug- esis an ; SCCmec: S aphylococcal
casse e ch omosome; ST: sequence ype; CC: clonal complex; PVL: Pan on-
Valen ine leukocidin; IEC: immune e asion clus e ; MRSA: me hicillin- esis an
S aphylococcus au eus; MRSP: me hicillin- esis an S aphylococcus
pseudin e medius; HA: hospi al-associa ed; CA: communi y-associa ed;
LA: li es ock-associa ed; CoPS: coagulase-posi i e s aphylococci;
PFGE: pulsed- ield gel elec opho esis; MSSP: me hicillin-suscep ible S.
pseudin e medius; MSSA: me hicillin-suscep ible S. au eus;
SCIN: s aphylococcal complemen inhibi o ; MLST: mul ilocus sequence
yping; CLSI: clinical labo a o y s anda ds ins i u e; PCR: polyme ase chain
eac ion; WGS: whole genome sequencing
Acknowledgemen s
The au ho s would like o hank D . Jose Manuel Ha o-Mo eno (Miguel He -
nandez Uni e si y, Spain), o his di ec suppo in WGS assembly and anno-
a ion o S. pseudin e medius C5347.
Au ho s’con ibu ions
LRR, SC and EGS ca ied ou he expe imen s and analyzed he da a. CS and
CO isola ed he s ains used in his wo k. MZ, CT and EGS designed he
p ojec and supe ised he esea ch. All au ho s d a ed he manusc ip and
app o ed i .
Funding
The de elopmen o his s udy was suppo ed by p ojec s SAF2012–35474
and SAF2016–76571-R om he Agencia Es a al de In es igación (AEI) o
Spain and he Fondo Eu opeo de Desa ollo Regional (FEDER) o EU and by
he Ins i u o A agonés de Ciencias de la Salud ICS o Spain. E. Gómez-Sanz
was ini ially unded by a ellowship om he Gobie no de La Rioja, Spain
(sample collec ion and expe imen al wo k) and la e on (da a analysis and
manusc ip e ision) by he Eu opean Union’s F amewo k P og am o
Resea ch and Inno a ion Ho izon 2020 (2014–2020) unde he Ma ie
Sklodowska-Cu ie G an Ag eemen No. 659314 and by in e nal unds o
ETHZ. Lau a Ruiz-Ripa has a p e-doc o al ellowship om he Uni e sidad de
La Rioja (Spain). The unding o ganisms nei he a ec he design o he e-
sea ch no he in e p e a ion o he da a.
A ailabili y o da a and ma e ials
The en i e ansposon Tn559 plus he unca ed adC gene o S.
pseudin e medius C5347, comp ising 5′069 bps, ha e been deposi ed in he
Genbank da abase wi h accession numbe MT252966.
E hics app o al and consen o pa icipa e
No applicable.
Consen o publica ion
No applicable.
Compe ing in e es s
The au ho s decla e ha hey ha e no compe ing in e es s.
Au ho de ails
1
Á ea Bioquímica y Biología Molecula , Uni e sidad de La Rioja, Log oño
26006, Spain.
2
Depa amen o de Pa ología Animal, Uni e sidad de Za agoza,
Za agoza 50013, Spain.
3
Ins i u e o Food, Nu i ion and Heal h, ETH Zü ich,
Schmelzbe gs asse 7, LFV B36, 8092 Zu ich, Swi ze land.
4
Á ea de
Mic obiología Molecula , Cen o de In es igación Biomédica de La Rioja
(CIBIR), Log oño 26006, Spain.
Recei ed: 23 Ap il 2020 Accep ed: 21 Decembe 2020
Re e ences
1. Bie owiec K, Ko zeniowska-Kowal A, Wzo ek A, Rypuła K, Gamian A.
P e alence o S aphylococcus species coloniza ion in heal hy and sick ca s.
Biomed Res In . 2019;2019:4360525.
2. Somayaji R, Rubin JE, P iyan ha MA, Chu ch D. Explo ing S aphylococcus
pseudin e medius: an eme ging zoono ic pa hogen? Fu u e Mic obiol. 2016;
11:1371–4.
3. Be go M, Ma ins-Simoes P, Kilian H, Châ e P, Wo hing KA, No is JM, e al.
E olu ion o he popula ion s uc u e o S aphylococcus pseudin e medius in
F ance. F on Mic obiol. 2018;9:3055.
4. Pi es Dos San os T, Dambo g P, Moodley A, Gua dabassi L. Sys ema ic
e iew on global epidemiology o me hicillin- esis an S aphylococcus
pseudin e medius: in e ence o popula ion s uc u e om Mul ilocus
Sequence Typing Da a. F on Mic obiol. 2016;7:1599.
5. an Duijke en E, Ca y B, G eko C, Mo eno MA, Pomba MC, Pyö älä S, e al.
Re iew on me hicillin esis an S aphylococcus pseudin e medius.J
An imic ob Chemo he . 2011;66(12):2705–14.
6. Gómez-Sanz E, To es C, Lozano C, Za azaga M. High di e si y o
S aphylococcus au eus and S aphylococcus pseudin e medius lineages and
oxigenic ai s in heal hy pe -owning household membe s.
Unde es ima ing no mal household con ac ? Comp Immunol Mic obiol
In ec Dis. 2013;36(1):83–94.
7. Kaspa U, on Lü zau A, Schla mann A, Roesle U, Köck R, Becke K.
Zoono ic mul id ug- esis an mic oo ganisms among small companion
animals in Ge many. Plos One. 2018;13(12):e0208364.
8. Haenni M, de Mo aes NA, Châ e P, Médaille C, Moodley A, Madec JY.
Cha ac e isa ion o clinical canine me icillin- esis an and me icillin-
suscep ible S aphylococcus pseudin e medius in F ance. J Glob An imic ob
Resis . 2014;2(2):119–23.
9. Cou o N, Monchique C, Belas A, Ma ques C, Gama LT, Pomba C. T ends and
molecula mechanisms o an imic obial esis ance in clinical s aphylococci
isola ed om companion animals o e a 16 yea pe iod. J An imic ob
Chemo he . 2016;71(6):1479–87.
10. Wo hing KA, Ab aham S, Coombs GW, Pang S, Sapu a S, Jo dan D, e al.
Clonal di e si y and geog aphic dis ibu ion o me hicillin- esis an
S aphylococcus pseudin e medius om Aus alian animals: disco e y o no el
sequence ypes. Ve Mic obiol. 2018;213:58–65.
11. Duim B, Ve s appen KM, B oens EM, Laa ho en LM, an Duijke en E, Ho dijk
J, e al. Changes in he popula ion o me hicillin- esis an S aphylococcus
pseudin e medius and dissemina ion o an imic obial- esis an pheno ypes in
he Ne he lands. J Clin Mic obiol. 2016;54(2):283–8.
12. Kawakami T, Shiba a S, Mu ayama N, Naga a M, Nishi uji K, Iwasaki T, e al.
An imic obial suscep ibili y and me hicillin esis ance in S aphylococcus
pseudin e medius and S aphylococcus schlei e i subsp. coagulans isola ed
om dogs wi h pyode ma in Japan. J Ve Med Sci. 2010;72(12):1615–9.
13. Pe e en V, Kadlec K, Schwa z S, Ande sson UG, Finn M, G eko C, e al.
Clonal sp ead o me hicillin- esis an S aphylococcus pseudin e medius in
Eu ope and No h Ame ica: an in e na ional mul icen e s udy. J An imic ob
Chemo he . 2010;65(6):1145–54.
14. Loe le A, P ei e DU, Lindsay JA, Soa es Magalhães RJ, Lloyd DH.
P e alence o and isk ac o s o MRSA ca iage in companion animals: a
su ey o dogs, ca s and ho ses. Epidemiol In ec . 2011;139(7):1019–28.
15. Wip JR, Pe e en V. Me hicillin- esis an S aphylococcus au eus isola ed om
dogs and ca s in Swi ze land. Schweiz A ch Tie heilkd. 2016;158(6):443–50.
16. Wi e W, S ommenge B, S anek C, Cuny C. Me hicillin- esis an
S aphylococcus au eus ST398 in humans and animals, Cen al Eu ope. Eme g
In ec Dis. 2007;13(2):255–8.
17. Sapu a S, Jo dan D, Wo hing KA, No is JM, Wong HS, Ab aham R, e al.
An imic obial esis ance in coagulase-posi i e s aphylococci isola ed om
companion animals in Aus alia: a one yea s udy. Plos One. 2017;12(4):
e0176379.
18. Gómez-Sanz E, To es C, Lozano C, Sáenz Y, Za azaga M. De ec ion and
cha ac e iza ion o me hicillin- esis an S aphylococcus pseudin e medius in
heal hy dogs in La Rioja, Spain. Comp Immunol Mic obiol In ec Dis. 2011;
34(5):447–53.
19. G ön hal T, Eklund M, Thomson K, Piipa inen H, Si onen T, Ran ala M.
An imic obial esis ance in S aphylococcus pseudin e medius and he
Ruiz-Ripa e al. BMC Ve e ina y Resea ch (2021) 17:42 Page 9 o 10